- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Survival of pancreatic cancer cells lacking KRAS function ; volume:8 ; number:1 ; day:23 ; month:10 ; year:2017 ; pages:1-19 ; date:12.2017
Nature Communications ; 8, Heft 1 (23.10.2017), 1-19, 12.2017
- Creator
-
Muzumdar, Mandar Deepak
Chen, Pan-Yu
Dorans, Kimberly Judith
Chung, Katherine Minjee
Bhutkar, Arjun
Hong, Erin
Noll, Elisa M.
Sprick, Martin
Trumpp, Andreas
Jacks, Tyler
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-017-00942-5
- URN
-
urn:nbn:de:101:1-2019081000534318926481
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Muzumdar, Mandar Deepak
- Chen, Pan-Yu
- Dorans, Kimberly Judith
- Chung, Katherine Minjee
- Bhutkar, Arjun
- Hong, Erin
- Noll, Elisa M.
- Sprick, Martin
- Trumpp, Andreas
- Jacks, Tyler
- SpringerLink (Online service)
Other Objects (12)
KSRP improves pancreatic beta cell function and survival
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma
Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma
Rapamycin increases survival in ALS mice lacking mature lymphocytes
Survival of adult neurons lacking cholesterol synthesis in vivo
Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma
Characterization of KRAS-driven epigenomic changes in pancreatic carcinogenesis
Targeting mutant KRAS in pancreatic cancer: futile or promising?
Evolutionary trajectories and KRAS dosage define pancreatic cancer phenotypes
TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
KSRP improves pancreatic beta cell function and survival
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma
Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma
Rapamycin increases survival in ALS mice lacking mature lymphocytes
Survival of adult neurons lacking cholesterol synthesis in vivo
Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma
Characterization of KRAS-driven epigenomic changes in pancreatic carcinogenesis
Targeting mutant KRAS in pancreatic cancer: futile or promising?
Evolutionary trajectories and KRAS dosage define pancreatic cancer phenotypes
TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
KSRP improves pancreatic beta cell function and survival
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma
Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma
Rapamycin increases survival in ALS mice lacking mature lymphocytes
Survival of adult neurons lacking cholesterol synthesis in vivo
Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma
Characterization of KRAS-driven epigenomic changes in pancreatic carcinogenesis
Targeting mutant KRAS in pancreatic cancer: futile or promising?
Evolutionary trajectories and KRAS dosage define pancreatic cancer phenotypes
TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma